Flavonoid apigenin is an inhibitor of the NAD+ase CD38: Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome (Diabetes (2013) 62 (1084-1093))

Carlos Escande, Veronica Nin, Nathan L. Price, Verena Capellini, Ana P. Gomes, Maria Thereza Barbosa, Luke O'Neil, Thomas A. White, David A. Sinclair, Eduardo N. Chini

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalDiabetes
Volume63
Issue number4
DOIs
StatePublished - Apr 1 2014

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this